Dengxiang Liu Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

5/2017

Expression of Rab5a correlates with tumor progression in pancreatic carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dengxiang Liu Research Topics

Disease

14	Neoplasms (Cancer) 02/2024 - 05/2017
7	Fibrosis (Cirrhosis) 10/2023 - 10/2018
6	Portal Hypertension 01/2022 - 10/2018
5	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 01/2022
4	Adenocarcinoma of Lung 02/2024 - 11/2020
4	Neoplasm Metastasis (Metastasis) 05/2023 - 01/2018
4	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2018
4	Liver Failure 01/2023 - 01/2022
2	Breast Neoplasms (Breast Cancer) 05/2023 - 04/2023
2	Lymphatic Metastasis 05/2023 - 01/2018
2	Liver Diseases (Liver Disease) 01/2023 - 01/2022
2	Pain (Aches) 11/2022 - 06/2022
2	COVID-19 06/2022 - 01/2021
2	Infections 01/2022 - 02/2020
2	Adenocarcinoma 01/2022 - 01/2021
1	Cicatrix (Scar) 08/2023
1	Anorexia 11/2022
1	Fatigue 06/2022
1	End Stage Liver Disease 01/2022
1	Hepatitis C 01/2022
1	Hyperbilirubinemia 01/2022
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Lung Neoplasms (Lung Cancer) 11/2020
1	Hypertension (High Blood Pressure) 02/2020
1	Proteinuria 02/2020
1	Diarrhea 02/2020
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2020
1	Hemorrhage 10/2019
1	Esophageal and Gastric Varices (Esophageal Varices) 10/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 05/2017
1	Pulmonary Embolism 01/2017

Drug/Important Bio-Agent (IBA)

4	COVID-19 VaccinesIBA 10/2023 - 01/2021
4	VaccinesIBA 11/2022 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2021
3	4-(3-chlorophenylsulfanyl)piperidineIBA 12/2021 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2022
2	IntegrinsIBA 02/2024 - 01/2023
2	Long Noncoding RNAIBA 04/2023 - 01/2021
2	AlbuminsIBA 01/2023 - 01/2022
2	Neutralizing AntibodiesIBA 06/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2017
1	Small Interfering RNA (siRNA)IBA 02/2024
1	Interleukin-6 (Interleukin 6)IBA 08/2023
1	Interleukin-10 (Interleukin 10)IBA 08/2023
1	Interleukin-13IBA 08/2023
1	ErbB Receptors (EGF Receptor)IBA 05/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2023
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2023
1	Docetaxel (Taxotere)FDA Link 05/2023
1	Trastuzumab (Herceptin)FDA Link 05/2023
1	Liposomes (Liposome)IBA 05/2023
1	liposomal doxorubicin (Doxil)FDA Link 05/2023
1	6-methyladenineIBA 04/2023
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2023
1	ElementsIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	GlobulinsIBA 01/2023
1	PoisonsIBA 12/2022
1	Proton Pump InhibitorsIBA 12/2022
1	Natural Killer Cell ReceptorsIBA 01/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022
1	BilirubinIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 11/2020
1	CrizotinibIBA 11/2020
1	apatinibIBA 02/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 02/2020
1	Therapeutic UsesIBA 02/2020
1	TerlipressinIBA 10/2019
1	Octreotide (Sandostatin)FDA LinkGeneric 10/2019
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	vandetanib (ZD6474)IBA 01/2018
1	CateninsIBA 05/2017
1	rab5 GTP-Binding ProteinsIBA 05/2017
1	fibrin fragment D (D-dimer)IBA 01/2017

Therapy/Procedure

5	Hepatectomy 01/2023 - 01/2021
3	Therapeutics 01/2023 - 01/2020
1	Neoadjuvant Therapy 05/2023
1	Immunotherapy 04/2023
1	Drug Therapy (Chemotherapy) 06/2018